1. Home
  2. WGSWW vs BPYPN Comparison

WGSWW vs BPYPN Comparison

Compare WGSWW & BPYPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GeneDx Holdings Corp.

WGSWW

GeneDx Holdings Corp.

HOLD

Current Price

$0.01

Market Cap

0.0

Sector

Technology

ML Signal

HOLD

Logo Brookfield Property Partners L.P. 5.750% Cumulative Redeemable Perpetual Preferred Units Series 3

BPYPN

Brookfield Property Partners L.P. 5.750% Cumulative Redeemable Perpetual Preferred Units Series 3

HOLD

Current Price

$13.97

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
WGSWW
BPYPN
Founded
2017
N/A
Country
United States
Bermuda
Employees
1300
24000
Industry
Retail: Computer Software & Peripheral Equipment
Real Estate
Sector
Technology
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WGSWW
BPYPN
Price
$0.01
$13.97
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
118.0K
15.6K
Earning Date
02-18-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$305,450,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
50.79
N/A
52 Week Low
$0.00
$12.51
52 Week High
$0.13
$14.88

Technical Indicators

Market Signals
Indicator
WGSWW
BPYPN
Relative Strength Index (RSI) 63.57 54.66
Support Level $0.00 $13.83
Resistance Level $0.02 $14.01
Average True Range (ATR) 0.00 0.08
MACD 0.00 -0.01
Stochastic Oscillator 79.85 77.27

Price Performance

Historical Comparison
WGSWW
BPYPN

About WGSWW GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

About BPYPN Brookfield Property Partners L.P. 5.750% Cumulative Redeemable Perpetual Preferred Units Series 3

Brookfield Property Partners LP owns, operates, andin North America, Europe, Australia, and Brazil. The company focuses on being an owner and operator of real estate, providing investors with diversified exposure to some of the iconic properties and acquiring high-quality assets at a discount to replacement cost or intrinsic value. Its operating segment includes Core Office, Core Retail, LP Investments, and Corporate Segments. The company operates in various sectors such as the office sector, retail sector, industrial, multifamily, hospitality, triple net lease, and corporate sector. It generates a majority of revenue from the LP Investments segment.

Share on Social Networks: